Physical urticaria (Q38015260)

27 August 2017

title

Physical urticaria (English)

1 reference

27 August 2017

1 reference

3

Marcus Maurer

1 reference

27 August 2017

Marina Abajian

1

1 reference

27 August 2017

Agnieszka Młynek

series ordinal

2

1 reference

27 August 2017

publication date

1 August 2012

1 reference

Current Allergy and Asthma Reports

27 August 2017

published in

1 reference

27 August 2017

volume

12

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

281-287

1 reference

Physical urticaria: classification and diagnostic guidelines. An EAACI position paper

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Physical urticaria: prevalence, type and natural course in a tropical country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Evaluation of patients with symptomatic dermographism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Urticaria and its subtypes: the role of second-generation antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Efficacy of omalizumab in delayed pressure urticaria: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Clinical features and anaphylaxis in children with cold urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Cold urticaria. Clinical findings in 220 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Modern approaches to the diagnosis and treatment of cold contact urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Acquired cold urticaria symptoms can be safely prevented by ebastine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Effective treatment of refractory severe heat urticaria with omalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Successful treatment of solar urticaria with anti-immunoglobulin E therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Solar urticaria unresponsive to intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Solar urticaria successfully treated with intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11882-012-0269-0

21 January 2018

Fixed solar urticaria

1 reference

12 December 2020

Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis

1 reference

12 December 2020

Delayed pressure urticaria - dapsone heading for first-line therapy?

1 reference

12 December 2020

Dermographism: an adverse effect of atorvastatin.

1 reference

12 December 2020

Urticaria: current opinions about etiology, diagnosis and therapy

1 reference

12 December 2020

Solar urticaria with delayed onset: a case report

1 reference

12 December 2020

UVA rush hardening for the treatment of solar urticaria

1 reference

12 December 2020

[Urticaria caused by cold. 104 cases]

1 reference

12 December 2020

Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light

1 reference

12 December 2020

[Epidemiology and clinical aspects of cold urticaria]

1 reference

12 December 2020

Cold urticaria: tolerance induction with cold baths

1 reference

12 December 2020

Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria

1 reference

12 December 2020

Solar urticaria: a report on 57 cases

1 reference

12 December 2020

Solar urticaria confined to areas of bruising

1 reference

12 December 2020

Two patients with solar urticaria manifesting pruritic erythema

1 reference

12 December 2020

Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria

1 reference

12 December 2020

Cold urticaria treated by induction of tolerance

1 reference

12 December 2020

Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin

1 reference

12 December 2020

Idiopathic Cold Urticaria: In Vitro Demonstration of Histamine Release upon Challenge of Skin Biopsies

1 reference

12 December 2020

Clinical Predictive Factors of Severity in Cold Urticaria

1 reference

12 December 2020

Association of dermographic urticaria with the use of progesterone in cottonseed oil

1 reference

12 December 2020

Multiple physical urticarias

1 reference

12 December 2020

Partial improvement of solar urticaria after omalizumab

1 reference

12 December 2020

Bruising and susceptibility to solar urticaria

1 reference

12 December 2020

Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report

1 reference

12 December 2020

Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes

1 reference

12 December 2020

Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

[Vibratory angioedema]

1 reference

12 December 2020

Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra)

1 reference

12 December 2020

10.1007/S11882-012-0269-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1033066907

0 references

1 reference